Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies

Conference contribution


Publication Details

Author(s): Wagner F, Brandl C, Emmerich C, Mackensen A, Nitschke L, Müller F
Publisher: AMER SOC HEMATOLOGY
Publishing place: WASHINGTON
Publication year: 2018
Conference Proceedings Title: BLOOD
ISSN: 0006-4971


FAU Authors / FAU Editors

Brandl, Carolin Dr.
Sonderforschungsbereich/Transregio 130 B-Zellen: Immunität und Autoimmunität
Mackensen, Andreas Prof. Dr.
Lehrstuhl für Innere Medizin V
Müller, Fabian Dr. med.
Medizinische Klinik 5 - Hämatologie und Internistische Onkologie
Nitschke, Lars Prof. Dr.
Professur für Genetik
Gsottberger, Franziska
Medizinische Klinik 5 - Hämatologie und Internistische Onkologie


How to cite

APA:
Wagner, F., Brandl, C., Emmerich, C., Mackensen, A., Nitschke, L., & Müller, F. (2018). Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.

MLA:
Wagner, Franziska, et al. "Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies." Proceedings of the 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA WASHINGTON: AMER SOC HEMATOLOGY, 2018.

BibTeX: 

Last updated on 2019-07-03 at 09:23